Evidence map›Paper›PMID 40171103›Full record

ReviewJournal of orthopaedic translation2025

Application of collagen in bone regeneration.

Rou Li, Shiqing Xu, Yanning Guo, Cong Cao, Jingchen Xu, Lijun Hao, Sai Luo, Xinyao Chen, Yuyang Du, Ye Li and 4 more

Abstract readReview
In one paragraph

Review in Journal of orthopaedic translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Natural Polymers in Guided Bone Regeneration (GBR).Journal of functional biomaterials · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rou LiChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.
Shiqing XuChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.
Yanning GuoChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.
Cong CaoChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.
Jingchen XuChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.
Lijun HaoThe Plastic and Aesthetic Center, The First Affiliated Hospital of Harbin Medical University, Heilongjiang Province, PR China.
Sai LuoThe Plastic and Aesthetic Center, The First Affiliated Hospital of Harbin Medical University, Heilongjiang Province, PR China.
Xinyao ChenThe Plastic and Aesthetic Center, The First Affiliated Hospital of Harbin Medical University, Heilongjiang Province, PR China.
Yuyang DuThe Plastic and Aesthetic Center, The First Affiliated Hospital of Harbin Medical University, Heilongjiang Province, PR China.
Ye LiDepartment of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guang Zhou 510515, PR China.
Yong XieDepartment of Cardiac Surgery, The First Affiliated Hospital of Tsinghua University, Beijing 100036, PR China.
Weitong GaoDepartment of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, PR China.
Jing LiChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.
Baohua XuChina-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing 100029, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, there is a significant population of individuals experiencing bone deficiencies caused by injuries, ailments affecting the bones, congenital abnormalities, and cancer. The management of substantial bone defects a significant global orthopedic challenge due to the intricacies involved in promoting and restoring the growth of fresh osseous tissue. Autografts are widely regarded as the "gold standard" for repairing bone defects because of their superior tissue acceptance and ability to control osteogenesis. However, patients undergoing autografts may encounter various challenges, including but not limited to hernia, bleeding, nerve impairment, tissue death. Therefore, researchers in regenerative medicine are striving to find alternatives. Collagen is the most abundant protein in the human body, and its triple helix structure gives it unique characteristics that contribute to its strength and functionality in various tissues. Collagen is commonly processed into various forms such as scaffolds, sponges, membranes, hydrogels, and composite materials, due to its unique compatibility with the human body, affinity for water, minimal potential for immune reactions, adaptability, and ability to transport nutrients or drugs. As an alternative material in the field of bone regeneration, collagen is becoming increasingly important. The objective of this review is to provide a comprehensive analysis of the primary types and sources of collagen, their processes of synthesis and degradation, as well as the advancements made in bone regeneration research and its potential applications. A comprehensive investigation into the role of collagen in bone regeneration is undertaken, providing valuable points of reference for a more profound comprehension of collagen applications in this field. The concluding section provides a comprehensive overview of the prospective avenues for collagen research, underscoring their promising future and highlighting their significant potential in the field of bone regeneration. The Translational Potential of this Article. The comprehensive exploration into the diverse functions and translational potential of collagen in bone regeneration, as demonstrated in this review, these findings underscore their promising potential as a treatment option with significant clinical implications, thus paving the way for innovative and efficacious therapeutic strategies in this domain.

Indexed as

BoneBone injuryRegenerative medicineTissue engineeringTranslational medicine

Identifiers

PMID40171103
PMCPMC11960539

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.